Drug combinations for the treatment of Duchenne muscular dystrophy

Details for Australian Patent Application No. 2008285289 (hide)

Owner Summit Corporation PLC

Inventors Storer, Richard; De Moor, Olivier; Johnson, Peter David; Pye, Richard Joseph; Dorgan, Colin Richard; Wren, Stephen Paul; Nugent, Gary; Wynne, Graham Michael; Price, Paul Damien

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008285289

PCT Pub. Number WO2009/019504

Priority 0715088.1 03.08.07 GB; 0807216.7 21.04.08 GB

Filing date 1 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2009/019504 Priority application(s): WO2009/019504

28 January 2010 Amendment Made

  The nature of the amendment is: Amend the applicant name from Summit Corporation PLC to Biomarin IGA Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285290-Drug combinations for the treatment of Duchenne muscular dystrophy

2008285286-Apparatus for the provision of topical negative pressure therapy